Lupin divests its U.S. Commercial Women's Health Specialty Business 0 15.07.2024 15:25 Business Standard Lupin announced today that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem), a U.S. biopharmaceutical company focused exclusively on Women's Health. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
